Prochlorperazine Edisylate Injection
Product Images NDC 23155-294

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Prochlorperazine Edisylate (NDC 23155-294). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ff8bf5ec 5505 471b Bfdf 7dab3618b50c 01

FDA Label Image

Ff8bf5ec 5505 471b Bfdf 7dab3618b50c 02

FDA Label Image

Ff8bf5ec 5505 471b Bfdf 7dab3618b50c 03

FDA Label Image

Ff8bf5ec 5505 471b Bfdf 7dab3618b50c 04

This is a pharmaceutical product with NDC code 23155-294-31, manufactured by Emcure Pharmaceuticals Ltd. in India. It contains 10 mg/2 mL solution meant for deep IM or IV use only and is not recommended for SC use. The product should be kept away from light and is available in a 2 mL multiple-dose vial with a prescription (Rx) for Avet Pharmaceuticals Inc.*

FDA Label Image

Ff8bf5ec 5505 471b Bfdf 7dab3618b50c 05

Prochlorperazine is a medication used to treat nausea and vomiting. This text shows information about the injection form of the medication, including the dosage, ingredients, and warnings not to use it in pediatric surgery. The text also includes storage instructions and the temperature range for safe use.*

FDA Label Image

Ff8bf5ec 5505 471b Bfdf 7dab3618b50c 06

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.